Findings support more targeted approach to cholesterol screens

Findings support more targeted approach to cholesterol screens

(HealthDay)—The prevalence of elevated cardiovascular risk is low in normotensive, nonsmoking women younger than 50 years and men younger than 40 years, according to a study published online May 16 in the Annals of Internal Medicine.

Krishna Patel, M.D., of Saint Luke's Health System in Kansas City, Mo., and colleagues analyzed data on 9,608 U.S. adults aged 30 to 49 who were part of a government health study. The team sought to evaluate the prevalence of elevated atherosclerotic
(ASCVD) risk among adults without diabetes who were younger than 50 years.

The researchers found that among nonsmokers with , very few were at heightened risk of ASCVD in the next 10 years. These findings held true as long as they didn't smoke or have . In the absence of those two risk factors, 0.09 percent of men younger than 40 were at elevated risk, while 0.04 percent of women younger than 50 were. Among male smokers in their 40s, one-half to three-quarters were at elevated risk.

"Given the low prevalence of patients at elevated cardiovascular risk, our findings would support the targeted approach of the U.S. Preventive Services Task Force over the more general screening of the American College of Cardiology and American Heart Association," the authors write.

More information: Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Journal information: Annals of Internal Medicine

Copyright © 2017 HealthDay. All rights reserved.

Citation: Findings support more targeted approach to cholesterol screens (2017, May 17) retrieved 7 May 2024 from https://medicalxpress.com/news/2017-05-approach-cholesterol-screens.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Adherence to USPSTF recommendations could lead to lower number of individuals recommended for statin

1 shares

Feedback to editors